These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 30934952
1. Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis. Eze FN, Leelawatwattana L, Prapunpoj P. Biomolecules; 2019 Mar 29; 9(4):. PubMed ID: 30934952 [Abstract] [Full Text] [Related]
2. Transthyretin Anti-Amyloidogenic and Fibril Disrupting Activities of Bacopa monnieri (L.) Wettst (Brahmi) Extract. Eze FN, Ingkaninan K, Prapunpoj P. Biomolecules; 2019 Dec 09; 9(12):. PubMed ID: 31835306 [Abstract] [Full Text] [Related]
3. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis. Wiseman RL, Green NS, Kelly JW. Biochemistry; 2005 Jun 28; 44(25):9265-74. PubMed ID: 15966751 [Abstract] [Full Text] [Related]
4. Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis. Foss TR, Kelker MS, Wiseman RL, Wilson IA, Kelly JW. J Mol Biol; 2005 Apr 08; 347(4):841-54. PubMed ID: 15769474 [Abstract] [Full Text] [Related]
5. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis. Liang Y, Ore MO, Morin S, Wilson DJ. Biochemistry; 2012 Apr 24; 51(16):3523-30. PubMed ID: 22482799 [Abstract] [Full Text] [Related]
6. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Green NS, Foss TR, Kelly JW. Proc Natl Acad Sci U S A; 2005 Oct 11; 102(41):14545-50. PubMed ID: 16195386 [Abstract] [Full Text] [Related]
7. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis. Hurshman Babbes AR, Powers ET, Kelly JW. Biochemistry; 2008 Jul 01; 47(26):6969-84. PubMed ID: 18537267 [Abstract] [Full Text] [Related]
8. Structural evidence for asymmetric ligand binding to transthyretin. Cianci M, Folli C, Zonta F, Florio P, Berni R, Zanotti G. Acta Crystallogr D Biol Crystallogr; 2015 Aug 01; 71(Pt 8):1582-92. PubMed ID: 26249340 [Abstract] [Full Text] [Related]
9. Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy. Hammarström P, Jiang X, Deechongkit S, Kelly JW. Biochemistry; 2001 Sep 25; 40(38):11453-9. PubMed ID: 11560493 [Abstract] [Full Text] [Related]
10. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. Green NS, Palaninathan SK, Sacchettini JC, Kelly JW. J Am Chem Soc; 2003 Nov 05; 125(44):13404-14. PubMed ID: 14583036 [Abstract] [Full Text] [Related]
11. Matrix metalloproteinase, hyaluronidase and elastase inhibitory potential of standardized extract of Centella asiatica. Nema NK, Maity N, Sarkar BK, Mukherjee PK. Pharm Biol; 2013 Sep 05; 51(9):1182-7. PubMed ID: 23763301 [Abstract] [Full Text] [Related]
12. The pathway by which the tetrameric protein transthyretin dissociates. Foss TR, Wiseman RL, Kelly JW. Biochemistry; 2005 Nov 29; 44(47):15525-33. PubMed ID: 16300401 [Abstract] [Full Text] [Related]
13. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Sekijima Y, Dendle MA, Kelly JW. Amyloid; 2006 Dec 29; 13(4):236-49. PubMed ID: 17107884 [Abstract] [Full Text] [Related]
14. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Sekijima Y, Kelly JW, Ikeda S. Curr Pharm Des; 2008 Dec 29; 14(30):3219-30. PubMed ID: 19075702 [Abstract] [Full Text] [Related]
15. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression. Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW. Amyloid; 2006 Jun 29; 13(2):57-66. PubMed ID: 16911959 [Abstract] [Full Text] [Related]
16. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW. Acc Chem Res; 2005 Dec 29; 38(12):911-21. PubMed ID: 16359163 [Abstract] [Full Text] [Related]
17. Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors. Connelly S, Mortenson DE, Choi S, Wilson IA, Powers ET, Kelly JW, Johnson SM. Bioorg Med Chem Lett; 2017 Aug 01; 27(15):3441-3449. PubMed ID: 28625364 [Abstract] [Full Text] [Related]
18. Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors. Guo X, Liu Z, Zheng Y, Li Y, Li L, Liu H, Chen Z, Wu L. Drug Des Devel Ther; 2020 Aug 01; 14():1057-1081. PubMed ID: 32210536 [Abstract] [Full Text] [Related]
19. [Studies on chemical constituents in herb of Centella asiatica]. Yu QL, Gao WY, Zhang YW, Teng J, Duan HQ. Zhongguo Zhong Yao Za Zhi; 2007 Jun 01; 32(12):1182-4. PubMed ID: 17802882 [Abstract] [Full Text] [Related]
20. Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) Urban. James JT, Dubery IA. Molecules; 2009 Oct 09; 14(10):3922-41. PubMed ID: 19924039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]